Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck & Co. Axes Alzheimer Deal with Acumen
Genetic Engineering News
Wednesday, December 21, 2011 - 1:11pm
tags:
Merck, Alzheimer's disease, Acumen, anti-ADDL
Breaking: Sunovion axes sales reps for asthma meds in consolidation move
Fierce Pharma
Wednesday, December 21, 2011 - 12:59pm
tags:
asthma, layoffs, drug reps, Sunovion
False Claims, Off-Label Prescribing & Doctors
Pharmalot
Wednesday, December 21, 2011 - 12:56pm
tags:
off-label, physicians, False Claims Act
Dendreon: Where Do Things Stand On Provenge Reimbursement?
Seeking Alpha
Wednesday, December 21, 2011 - 12:56pm
tags:
Provenge, prostate cancer, Dendreon
Exelixis Licenses PI3K-Delta Program to Merck
Yahoo
Wednesday, December 21, 2011 - 12:55pm
tags:
Merck, Exelixix, P13K-Delta, XL-499
Teva Forecasts $22 Billion Sales in 2012
TheStreet.com
Wednesday, December 21, 2011 - 11:02am
tags:
Teva Pharmaceuticals
Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist for Asthma
Stock Markets Review
Wednesday, December 21, 2011 - 10:58am
tags:
Dynavax, AstraZeneca, toll-like Receptor (TLR) 9 agonist, AZD 1419, asthma
2-Star Stocks Poised to Plunge: Progenics?
Motley Fool
Wednesday, December 21, 2011 - 10:56am
tags:
Progenics Pharmaceuticals
Ranbaxy Pays $500M For Manufacturing Problems
Pharmalot
Wednesday, December 21, 2011 - 9:04am
tags:
Ranbaxy, drug manufacturing
[video]Antigen Express Breast Cancer Vaccine Development
Bloomberg
Wednesday, December 21, 2011 - 9:03am
tags:
breast cancer, Antigen, vaccines
Health Care's Hottest Duo
Motley Fool
Wednesday, December 21, 2011 - 9:01am
tags:
Gilead, Pharmasset, hepatitis C, Achillion, Inhibitex
Lundbeck seeks Europe approval for alcohol drug
Reuters
Wednesday, December 21, 2011 - 8:48am
tags:
Europe, Lundbeck, Selincro, alcoholism
Zogenix, Astellas to end co-promotion for migraine injection
Reuters
Wednesday, December 21, 2011 - 8:35am
tags:
Astellas, Zogenix, migraines, Sumavel DosePro
Takeda To Buy Small-Molecule Drug Maker For Up To $310 Million
WSJ Online
Tuesday, December 20, 2011 - 7:56pm
tags:
Takeda, small molecule drugs, M&A, Intellikine
What's Up With the Back-Slapping, Sequenom?
Motley Fool
Tuesday, December 20, 2011 - 7:51pm
tags:
Sequenom, Downs Syndrome, MaterniT21
AP Pharma's APF530 Poised To Return To FDA Review
Seeking Alpha
Tuesday, December 20, 2011 - 7:50pm
tags:
APF530, AP Pharma, FDA, chemotherapy-induced nausea and vomiting, CINV
FDA accepts application for Pfizer arthritis drug
Yahoo/AP
Tuesday, December 20, 2011 - 7:49pm
tags:
Pfizer, FDA, rheumatoid arthritis, tofacitinib
Generics makers step up for shortages response
Fierce Drug Manufacturing
Tuesday, December 20, 2011 - 12:12pm
tags:
generics, drug shortages
Progenics, Salix Surge After Constipation Drug Shows Benefits in Trial
Bloomberg
Tuesday, December 20, 2011 - 12:09pm
tags:
Salix, Progenics Pharmaceuticals, methylnaltrexone, opiod-induced constipation
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Tuesday, December 20, 2011 - 11:24am
tags:
Bayer, Xarelto, VEGF Trap-Eye, regorafenib, Alpharadin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.